Percutaneous Coronary Interventions Using a Ridaforolimus‐Eluting Stent in Patients at High Bleeding Risk

Percutaneous Coronary Interventions Using a Ridaforolimus‐Eluting Stent in Patients at High Bleeding Risk

Background Patients treated with percutaneous coronary intervention are often considered to be at a high bleeding risk (HBR). Drug‐eluting stents have been shown to be superior to bare‐metal stents in patients with HBR, even when patients were given abbreviated periods of dual antiplatelet therapy (...

全面介绍

书目详细资料
Main Authors: Ran Kornowski, Maayan Konigstein, Michael Jonas, Abid Assali, Hana Vaknin‐Assa, Amit Segev, Haim Danenberg, Majdi Halabi, Ariel Roguin, Arthur Kerner, Eli Lev, Grigoris V. Karamasis, Thomas W. Johnson, Richard Anderson, Jonathan Blaxill, Sachin Jadhav, Stephen Hoole, Guy Witberg, Melek Ozgu Issever, Ori Ben‐Yehuda, Andreas Baumbach
格式: 文件
语言:English
出版: Wiley 2024-01-01
丛编:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主题:
antithrombotic therapy
coronary artery disease
high bleeding risk
percutaneous coronary intervention
在线阅读:https://www.ahajournals.org/doi/10.1161/JAHA.122.029051

因特网

https://www.ahajournals.org/doi/10.1161/JAHA.122.029051

相似书籍